Skip to main content
SpringerLink
Log in

Adefovir/entecavir/lamivudine

Acquired drug resistance resulting in a viral breakthrough: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kim JH, et al. Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers. Antimicrobial Agents and Chemotherapy 66: No. 8, 2022. Available from: URL: http://doi.org/10.1128/aac.00275-22

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adefovir/entecavir/lamivudine. Reactions Weekly 1924, 26 (2022). https://doi.org/10.1007/s40278-022-23379-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-23379-0

Search

Navigation